NCT02521623View on ClinicalTrials.gov

SurgiMend® vs. Strattice™ in Direct to Implant Breast Reconstruction- A Prospective Randomized Trial

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Breast Neoplasms
Interventions
DEVICE

SurgiMend® Acellular Dermal Matrix

See arm description.

DEVICE

Strattice™ Acellular Dermal Matrix

See arm description.

Trial Locations (1)

8000

Dept. of Plastic Surgery, Aarhus University Hospital, Aarhus C

All Listed Sponsors
lead

Aarhus University Hospital

OTHER

NCT02521623 - SurgiMend® vs. Strattice™ in Direct to Implant Breast Reconstruction- A Prospective Randomized Trial | Biotech Hunter | Biotech Hunter